Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease
Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8633-8633
Open Access | Times Cited: 21

Showing 21 citing articles:

Role of histone deacetylases and their inhibitors in neurological diseases
Liying Zhang, Sen-Yu Zhang, Ri Wen, et al.
Pharmacological Research (2024), pp. 107410-107410
Open Access | Times Cited: 16
Epigenetics in Neurodegenerative Diseases
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access | Times Cited: 1
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Márcia S. Pereira, Maria Teresa Cruz, Ana Fortuna, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104052-104052
Open Access | Times Cited: 8
Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease
Yanyan Kong, Cinzia Maschio, Xuefeng Shi, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8387-8401
Open Access | Times Cited: 7
Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)
Junyan Gao, Liping Li
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 13
A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway
Ying Han, Le Chen, Jingyun Liu, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4160-4160
Open Access | Times Cited: 20
Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
Liesbeth Everix, Elsie Neo Seane, Thomas Ebenhan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 227-227
Open Access | Times Cited: 12
Neuroimaging of Mouse Models of Alzheimer’s Disease
Amandine Jullienne, Michelle V. Trinh, André Obenaus
Biomedicines (2022) Vol. 10, Iss. 2, pp. 305-305
Open Access | Times Cited: 17
Correlation between Olfaction and Cognition Using PET Quantification of Alzheimer’s Disease Biomarkers in Intracranial Olfactory-Related Regions of 3xTg Mice
Yulin Wang, Wanchen Liao, Kai-Fan Ye, et al.
Molecular Pharmaceutics (2025)
Closed Access
The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases
Seth Mikaye Monayo, Xin Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Epigenetic Changes and Chromatin Reorganization in Brain Function: Lessons from Fear Memory Ensemble and Alzheimer’s Disease
Brigitte van Zundert, Martı́n Montecino
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12081-12081
Open Access | Times Cited: 13
Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications
Ruiqing Ni
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1179-1179
Open Access | Times Cited: 16
Oxyresveratrol-β-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies
Tushar Agarwal, Suman Manandhar, Harish Kumar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Targeting epigenetic mechanisms in amyloid-β–mediated Alzheimer’s pathophysiology: unveiling therapeutic potential
Jennie Z. Li, Nagendran Ramalingam, Shaomin Li
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 54-66
Open Access | Times Cited: 1
HEXIM1 is correlated with Alzheimer's disease pathology and regulates immediate early gene dynamics in neurons
Myo Htet, Camila Estay-Olmos, Lan Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Targeting S100A9 attenuates social dysfunction by modulating neuroinflammation and myelination in a mouse model of autism
Hong Gong, Lu Yao, Shilong Deng, et al.
Pharmacological Research (2024) Vol. 211, pp. 107568-107568
Open Access | Times Cited: 1
Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer’s disease
Yanyan Kong, Cinzia Maschio, Xuefeng Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Gut Microbiota Defined Epigenomes of Alzheimer’s and Parkinson’s Diseases Reveal Novel Targets for Therapy
Shabnam Nohesara, Hamid M. Abdolmaleky, Sam Thiagalingam, et al.
Epigenomics (2023) Vol. 16, Iss. 1, pp. 57-77
Closed Access | Times Cited: 3
Deciphering the roles of subcellular distribution and interactions involving the MEF2 binding region, the ankyrin repeat binding motif and the catalytic site of HDAC4 in Drosophila neuronal morphogenesis
Wei Jun Tan, Hannah R. Hawley, Sarah J. Wilson, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access
Oxyresveratrol-β-cyclodextrin mitigates intracerebral STZ-induced Alzheimer’s disease via suppression of hippocampal and cortical cognitive impairment and histone deacetylase activity in rats: In silico and In vivo studies
Tushar Agarwal, Suman Manandhar, Harish Kumar, et al.
Research Square (Research Square) (2023)
Open Access
Histone Deacetylase Inhibitors: Design, Synthesis, and Biological Evaluation
Sravani Pulya, Abhiram Ganorkar, Swati Biswas, et al.
(2023), pp. 427-447
Closed Access
Page 1

Scroll to top